Article Details

Merck KGaA snaps up German CDMO in boost to mRNA portfolio — including for Covid-19

Retrieved on: 2021-01-08 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

Merck KGaA snaps up German CDMO in boost to mRNA portfolio — including for Covid-19. View article details on hiswai:

Excerpt

The Darmstadt, Germany based biopharma has acquired mRNA CDMO AmpTec in Hamburg, saying it plans to strengthen its own capacities to ...

Article found on: endpts.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo